Stevens Capital Management LP Novartis Ag Transaction History

Stevens Capital Management LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$78.07 - $94.43 $335,544 - $405,860	-4,298 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $353,037 - $391,118	4,298 New	4,298 $374,000
Q1 2020 Apr 21, 2020	SELL	$70.67 - $99.01 $149,961 - $210,099	-2,122 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$84.35 - $95.37 $473,119 - $534,930	-5,609 Reduced 72.55%	2,122 $201,000
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $120,269 - $132,529	-1,406 Reduced 15.39%	7,731 $672,000
Q2 2019 Jul 31, 2019	BUY	$75.4 - $92.8 $688,929 - $847,913	9,137 New	9,137 $834,000
Q4 2018 Feb 06, 2019	SELL	$73.66 - $82.02 $420,451 - $468,170	-5,708 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $830,993 - $961,216	-12,414 Reduced 68.5%	5,708 $492,000
Q2 2018 Aug 09, 2018	BUY	$64.91 - $73.36 $248,475 - $280,822	3,828 Added 26.78%	18,122 $1.37 Million
Q1 2018 May 08, 2018	SELL	$70.39 - $84.15 $76,302 - $91,218	-1,084 Reduced 7.05%	14,294 $1.16 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $738,923 - $793,170	10,216 Added 197.91%	15,378 $1.29 Million
Q3 2017 Nov 01, 2017	BUY	$74.14 - $77.27 $382,710 - $398,867	5,162	5,162 $443,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.